{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:07:11Z","timestamp":1785550031691,"version":"3.56.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jjcc.2026.03.011","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T01:03:39Z","timestamp":1774487019000},"page":"129-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of running average value of non-fasting serum triglyceride for secondary prevention of coronary artery disease"],"prefix":"10.1016","volume":"88","author":[{"given":"Ichiro","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensaku","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Kurozumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunetatsu","family":"Namba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2026.03.011_bb0005","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0010","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Bor\u00e9n","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ypmed.2011.02.019","article-title":"Low-density lipoprotein cholesterol and risk of coronary heart disease among Japanese men and women: coronary risk in community study (CIRCS)","volume":"52","author":"Imano","year":"2011","journal-title":"Prev Med"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0020","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/heartjnl-2020-318760","article-title":"Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges","volume":"107","author":"Packard","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidemia: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0030","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1161\/CIRCULATIONAHA.117.032615","article-title":"High-dose versus low-dose pitavastatin in Japanese patients with stable coronary artery disease (REAL-CAD): a randomized superiority trial","volume":"137","author":"Taguchi","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0035","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jjcc.2024.05.011","article-title":"Prognostic significance of baseline low-density lipoprotein cholesterol in patients undergoing coronary revascularization; a report from the CREDO-Kyoto registry","volume":"84","author":"Kanenawa","year":"2024","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jjcc.2023.10.002","article-title":"The real-world data of lipid-lowering treatment in patients with peripheral artery disease and its association with severity of disease","volume":"84","author":"Komai","year":"2024","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0045","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1194\/jlr.R082271","article-title":"Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding","volume":"59","author":"Sniderman","year":"2018","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0050","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0055","doi-asserted-by":"crossref","first-page":"3H","DOI":"10.1016\/0002-9149(92)91083-G","article-title":"Epidemiology of triglycerides: a view from Framingham","volume":"70","author":"Castelli","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0060","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/aje\/153.5.490","article-title":"Serum triglycerides and risk of coronary heart disease among Japanese men and women","volume":"153","author":"Iso","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0065","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.5551\/jat.63081","article-title":"Diabetes mellitus modifies the association of serum triglycerides with ischemic cardiovascular disease mortality: the Ibaraki Prefectural Health Study (IPHS)","volume":"29","author":"Yamagishi","year":"2022","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0070","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.5551\/jat.62730","article-title":"The risk of fasting triglycerides and its related indices for ischemic cardiovascular diseases in Japanese community dwellers: the Suita Study","volume":"28","author":"Higashiyama","year":"2021","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0075","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.atherosclerosis.2014.08.028","article-title":"Fasting and non-fasting triglycerides and risk of ischemic cardiovascular disease in Japanese men and women: the Circulatory Risk in Communities Study (CIRCS)","volume":"237","author":"Iso","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0080","doi-asserted-by":"crossref","first-page":"641","DOI":"10.5551\/jat.GL2022","article-title":"Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2022","volume":"31","author":"Okamura","year":"2024","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/01.ATV.11.1.2","article-title":"Plasma triglyceride and coronary heart disease","volume":"11","author":"Austin","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0090","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0095","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0100","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41569-022-00676-y","article-title":"Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia","volume":"19","author":"Bor\u00e9n","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0105","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0002-9343(01)00643-X","article-title":"Hypertriglyceridemia and other factors associated with plasma viscosity","volume":"110","author":"Rosenson","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0110","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/cvr\/cvn082","article-title":"Influence of postprandial triglyceride-rich lipoproteins on lipid-mediated gene expression in smooth muscle cells of the human coronary artery","volume":"79","author":"Berm\u00fadez","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jjcc.2026.03.011_bb0115","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1056\/NEJMoa2210645","article-title":"Triglyceride lowering with pemafibrate to reduce cardiovascular risk","volume":"387","author":"Pradhan","year":"2022","journal-title":"N Engl J Med"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508726000675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508726000675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:41:18Z","timestamp":1785548478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508726000675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0914508726000675"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2026.03.011","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of running average value of non-fasting serum triglyceride for secondary prevention of coronary artery disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2026.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd on behalf of Japanese College of Cardiology.","name":"copyright","label":"Copyright"}]}}